Trademark: 78790767
Word
EPIGENESIS PHARMACEUTICALS
Status
Dead
Status Code
606
Status Date
Monday, January 11, 2010
Serial Number
78790767
Mark Type
4000
Filing Date
Thursday, January 12, 2006
Published for Opposition
Tuesday, September 19, 2006
Abandoned Date
Monday, January 11, 2010

Trademark Owner History
Epigenesis Pharmaceuticals, LLC - Owner At Publication

Classifications
5 medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
"PHARMACEUTICALS"

Trademark Events
Jan 11, 2010
Abandonment Notice Mailed - No Use Statement Filed
Jan 11, 2010
Abandonment - No Use Statement Filed
Jun 30, 2009
Extension 5 Granted
Jun 8, 2009
Extension 5 Filed
Jun 30, 2009
Case Assigned To Intent To Use Paralegal
Jun 8, 2009
Teas Extension Received
Dec 1, 2008
Extension 4 Granted
Dec 1, 2008
Extension 4 Filed
Dec 1, 2008
Teas Extension Received
Jun 4, 2008
Extension 3 Granted
Jun 4, 2008
Extension 3 Filed
Jun 4, 2008
Teas Extension Received
Dec 3, 2007
Extension 2 Granted
Dec 3, 2007
Extension 2 Filed
Dec 3, 2007
Teas Extension Received
Jun 5, 2007
Extension 1 Granted
Jun 5, 2007
Extension 1 Filed
Jun 5, 2007
Teas Extension Received
Dec 12, 2006
Noa Mailed - Sou Required From Applicant
Sep 19, 2006
Published For Opposition
Aug 30, 2006
Notice Of Publication
Jul 27, 2006
Law Office Publication Review Completed
Jul 21, 2006
Assigned To Lie
Jul 17, 2006
Approved For Pub - Principal Register
Jul 13, 2006
Examiner's Amendment Entered
Jul 13, 2006
Examiners Amendment E-Mailed
Jul 13, 2006
Examiners Amendment -Written
Jun 29, 2006
Assigned To Examiner
Jan 18, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24